Clinical Trial

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Name: A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) — clinical trial record (NCT06456580)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.

Protocol Amendment History 2 changes

notable Trial sites expanded: 105 -> 111 locations 2026-06-19

notable Trial sites expanded: 84 -> 105 locations 2026-05-08

Trial Details

NCT Number	NCT06456580
Lead Sponsor	Vor Biopharma
Conditions	Generalized Myasthenia Gravis
Enrollment	180 participants
Start Date	2024-07-17
Primary Completion	2027-05 (estimated)
Study Completion	2029-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-18